| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Internet Marketing > To Be an Employee or Shareholder or Be an Internet Marketer |
|
Main Subject - To Be an Employee or Shareholder or Be an Internet Marketer
In any traditional business, you are always taught that you must have the self mentality to be successful According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product . But there will always be people who will put you down; they will try to "set you down to where you bel ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ng". We understand that some of them have good intentions, to warn us before we start trickling down to lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ailure but sometimes, we need to mix with more positive and successful people. In the working world, we here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe re always given a task to do and we just do it. Regardless of the bad weather, the latest in fashion, th d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e worst disaster in the world, we are safe in the arms of our employers. But when there is an economic d ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc wnturn, we will get hit very hard! So should we wait until the economy is down before we start sourcing easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi or an alternative income? The answer is an obvious "NO". In good times, or in bad times, we must always nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically source for a residual income. In my line of work when I was under a public listed company, no matter how and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ hard you work, how resourceful you are, the people who get rewarded are not the employees, not the manag ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi rs, but the shareholders. People who have the money to invest will be rewarded heavily. We may be the o ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a es cheering when we are given a 3 month bonus, but the amounts of payout to the shareholders are even big dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod er and more rewarding. Why? Because they are just a little bit of their time to study the companies tha cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin t they want to invest and using their money to invest while we, the employees are slogging our time, maki tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen g the company rich, and repaying them for the money invested in the company. So tell me, which position t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel o you want to be in? As a shareholder or as an employee? So let’s weigh the options, if you are rich, o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust some spare cash, you can always be an investor and build your money through investing. But if you are i y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products n need of cash, what are your options? How about considering being an internet marketer? Why? Simple. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ow cost and huge customer base potential and very interesting aspect is this; you need not be a "somebody elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip in the real world to succeed. If you are interested, start doing your research. You will not regret it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Using Invoice Discounting for Cash Flow Non Verbal Communication is also Work Place Communication
|